Dr. Daniel Kopans

Breast
Dr. Daniel Kopans: Will the USPSTF heed science on breast screening?
The U.S. Preventive Services Task Force (USPSTF) has begun a review of its guidelines on breast screening. Dr. Daniel Kopans believes the task force should heed the established science on mammography and recommend screening of women in their 40s.
January 28, 2021
2016 10 11 13 31 21 852 Am Second Opinion 400
Breast
Kopans: New NEJM paper offers rehash on 'overdiagnosis'
In this Second Opinion article, Dr. Daniel Kopans of Massachusetts General Hospital comments on a paper on breast screening by Welch et al published this week in the New England Journal of Medicine. The Welch paper is based on false assumptions and makes the same mistakes as a 2012 paper on the same topic, according to Kopans.
October 12, 2016
2016 10 11 13 31 21 852 Am Second Opinion 400
Breast
Kopans: JAMA Oncology paper misinterprets DCIS data
Just how deadly is ductal carcinoma in situ (DCIS)? A paper by Narod et al published on August 20 in JAMA Oncology suggests that the best way to deal with DCIS is simply to ignore it, rather than treating it aggressively. But such conclusions represent a dangerous misinterpretation of the actual data, according to Dr. Daniel Kopans.
August 23, 2015
2013 04 29 15 33 22 49 Kopans Daniel 200 20130429223516
Home
A response to Harding et al
The ploy used by Harding et al in their new study is classic. Explain why using your approach is scientifically unsupportable, and then go ahead and use it claiming there is no alternative.
July 5, 2015
Dr. Daniel Kopans from Massachusetts General Hospital.
Breast
Dr. Daniel Kopans: Topol ignores facts on mammography
In this Second Opinion article, Dr. Daniel Kopans of Massachusetts General Hospital offers a rebuttal of a May 6 column by cardiologist Dr. Eric Topol that calls for an end to routine mammography screening. Dr. Kopans believes the column misinterprets the facts about breast screening.
May 6, 2015
2013 06 03 12 02 47 211 Second Opinion Am 200
Breast
Dr. Daniel Kopans: On the draft USPSTF breast screening guidelines
In this Second Opinion article, Dr. Daniel Kopans offers his perspective on the release this week of new guidelines on screening mammography from the U.S. Preventive Services Task Force (USPSTF) -- guidelines that he believes will restrict access to mammography.
April 20, 2015
2013 06 03 12 02 47 211 Second Opinion Am 200
Breast
Kopans: Attacks on mammography are part of coordinated effort
In this Second Opinion article, breast imaging expert Dr. Daniel Kopans of Massachusetts General Hospital offers his perspective on the rising number of research studies with negative findings on screening mammography.
April 27, 2014
2013 06 03 12 02 47 211 Second Opinion Am 200
Breast
Kopans: Breast cancer overdiagnosis grossly exaggerated
In this Second Opinion article, breast imaging expert Dr. Daniel Kopans offers his rebuttal of a study published last November in the New England Journal of Medicine, which raised questions about the value of screening mammography and claimed that a third of detected breast cancers represent "overdiagnosis."
April 29, 2013
2013 04 29 15 33 22 49 Kopans Daniel 200 20130429223516
Breast
Shock and awe over JAMA editorial
The University of California, San Francisco researchers who authored this week's JAMA editorial on screening have disregarded the facts regarding the value of screening mammography, according to Dr. Daniel Kopans, who shares his view in this AuntMinnie Second Opinion.
October 21, 2009
2009 06 23 14 37 33 976 Second Opinion Am
Breast
DBT: Not a panacea, but promising technology is unfairly panned
The debate over the relative value of digital breast tomosynthesis (DBT) for cancer screening continues with Dr. Daniel Kopans, founder of the breast imaging division at Massachusetts General Hospital in Boston, who offers an opinion on the technology.
October 29, 2007
2007 10 01 09 05 35 706
Page 1 of 1
Top Stories
Chatgpt
Artificial Intelligence
LLMs decrease in accuracy over time on radiology exams
Large language models (LLMs) demonstrate high accuracy on radiology exams, yet decrease in accuracy over time.
Vaping E Cigarette Man
MRI
Functional MRI illuminates what motivates e-cigarette use
Radiologist Computer Screen X Ray
Womens Imaging
Student-led initiative working to close gender gap in radiology
Heart Pulmonary Trunk
CT
CT-defined CAC predicts cardiovascular events in lung cancer patients
Coffta Sandy Thumbnail
Economics
Medicare finalizes 2025 Fee Schedule cut
More in Home
LLMs decrease in accuracy over time on radiology exams
By Will Morton
Large language models (LLMs) demonstrate high accuracy on radiology exams, yet decrease in accuracy over time.
November 21, 2024
Chatgpt
Functional MRI illuminates what motivates e-cigarette use
By Kate Madden Yee
Functional MRI shows that e-cigarette users perceive the product as equally rewarding as money -- a finding that highlights the addictive potential of vaping.
November 21, 2024
Vaping E Cigarette Man
Student-led initiative working to close gender gap in radiology
By Amerigo Allegretto
A student-led initiative called Women in Radiology Education (WIRED) is working to close the gender gap in radiology.
November 20, 2024
Radiologist Computer Screen X Ray
CT-defined CAC predicts cardiovascular events in lung cancer patients
By Kate Madden Yee
CT-defined coronary artery calcification (CAC) scores can help predict the occurrence of conditions such as heart attack or stroke in lung cancer patients.
November 20, 2024
Heart Pulmonary Trunk
Medicare finalizes 2025 Fee Schedule cut
By Sandy Coffta
In a new column, Sandy Coffta of Healthcare Administrative Partners assesses how the 2025 Medicare Physician Fee Schedule Final Rule will impact radiology.
November 20, 2024
Coffta Sandy Thumbnail
Share of nonphysician practitioners' imaging interpretation doubles
By Kate Madden Yee
Nonphysician practitioners' share of imaging interpretation in office-based medical practices has more than doubled over the past decade.
November 20, 2024
Mammo Reading
Nomogram model predicts malignancy risk in ovarian masses
By Amerigo Allegretto
A nomogram model based on O-RADS ultrasound findings and clinical and lab indicators can predict malignancy risk in adnexal cystic-solid masses.
November 19, 2024
Ovarian Cancer Social
PET links chronic stress to aggressive endometrial cancer
By Will Morton
Brain activity related to chronic stress may be associated with the aggressiveness of tumors in women with endometrial cancer.
November 19, 2024
Pet Amygdala Thumbnail
Head CT offers insight into old strokes
By Kate Madden Yee
Incidental discovery of old strokes on head CT imaging offers clinicians an opportunity to put measures against future strokes into place.
November 19, 2024
Brain Stroke
Climate change boosts emergency department use of x-ray, CT
By Kate Madden Yee
Climate change's effects -- particularly higher outdoor heat and air pollution -- increase imaging use in the emergency department, especially x-ray and CT.
November 19, 2024
Earth Thumbnail
Radiologists prefer local AI advice over global
By Will Morton
Radiologists and other physicians tend to trust AI more when the algorithms provide local rather than global explanations of findings on chest x-rays.
November 19, 2024
Ai Explainability2 673bc0b7a0c1f Thumbnail
FAPI-PET/CT superior to FDG-PET/CT in assessing liver cancer
By Will Morton
A recent study suggests that PET/CT imaging with a FAPI radiotracer is superior to F-18 FDG-PET/CT for assessing patients with liver cancer.
November 18, 2024
Two cases of pathologically confirmed intrahepatic cholangiocarcinomas in 68-year-old male patients. In both cases (A-H, case 1; I-P, case 2), CT scans (B, F, case 1; J, N, case 2) revealed intrahepatic bile duct dilation and suspected nodular lesions. While F-18 FDG PET/CT (A, C, D, case 1; I, K, L, case 2) failed to demonstrate abnormal tracer uptake (SUVmax 3.5, TBR 1.3 in Case 1; SUVmax 2.6, TBR 1.2 in Case 2), F-18 FAPI-04 PET/CT (E, G, H, case 1; M, O, P, case 2 ) showed positive uptake in the nodular lesions (SUVmax 9.7, TBR 3.5 in Case 1; SUVmax 9.6, TBR 3.3 in Case 2). Image available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of BMC Cancer.
Page 1 of 100
Next Page